IL4 and cancer: Using an orthotropic breast cancer xenograft model in NOD/SCID mice, IL-4-treated THP-1 or THP-1/shCXCL1 cells were co-injected with MDA-MB-231 cancer cells into the mammary fat pads of NOD/SCID mice at a ratio of 1:3.